These 5 Stocks are Falling Today

In this article, we discuss the 5 stocks that are falling today. If you want to check out some other companies losing value on Wednesday, go directly to These 10 Stocks are Falling Today.

5. Altimmune, Inc. (NASDAQ:ALT)

Number of Hedge Fund Holders: 27

Altimmune, Inc. (NASDAQ:ALT) announced positive results from its Phase 1b trial of pemvidutide this morning. Yet, its shares took a deep dive after the opening bell on Wednesday, losing more than 40 percent of their value.

The drop came even after Altimmune, Inc. (NASDAQ:ALT) reported that it achieved its key targets in patients with non-alcoholic fatty liver disorder (NAFLD). According to Altimmune, Inc. (NASDAQ:ALT), the study also achieved the secondary goal of weight loss in all three groups.

Pipe Sandler said it was “surprised” to see the market reacting negatively to ALT’s results. The investment firm said the reaction was perhaps due to the 4.7% weight-loss reported in the study which came in below Street estimates.

Discussing the trial’s results, CEO of Altimmune, Inc. (NASDAQ:ALT), Vipin K. Garg, said in a statement:

“We are pleased with the results of this trial, including the extent of liver fat and serum ALT reductions. Weight loss was within our target range, and good tolerability was observed without the need for dose titration.”